InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,697.11
(
-1.04%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: adreamer post# 13956

Tuesday, 11/08/2011 9:37:45 AM

Tuesday, November 08, 2011 9:37:45 AM

Post# of 80490
>Given the way this trades I don't think we should expect any appreciation at ASH with more complete data...<

I respectfully disagree.
Look back how we traded around ASCO.
All indications are that the drug is more effective over time.

I can not fathom the meaning of the "expectations were for pristine data" comment from Merrill.
Was there any way one could expect more "pristine data" based on the phase 1 results?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up